Esohap-IT Capsule is a combination medicine used to treat acidity, gastro-oesophageal reflux disease (GERD), stomach ulcers (peptic ulcers, gastric ulcers due to H pylori), heartburn symptoms and Zollinger Ellison syndrome. Gastroesophageal reflux disease occurs when stomach acid frequently flows back into the food pipe (oesophagus). Peptic ulcers are sores that develop on the inner lining of the intestine and stomach. A gastric ulcer occurs mainly due to a bacteria known as H pylori which irritate and weakens the upper protective layer or mucous of the stomach leading to sores and ulcer. 
 
Esohap-IT Capsule is a combination of two drugs, namely: Esomeprazole and Itopride. Esomeprazole is a proton pump inhibitor (PPIs) which works by blocking the action of an enzyme called gastric proton pump responsible for the production of stomach acid. Itopride is a gastroprokinetic agent which works by increasing the gastric emptying time, thereby improving the movement/motility of the food pipe, stomach and intestine. Together, Esohap-IT Capsule helps in preventing acid reflux, thereby providing relief from symptoms of excessive stomach acid production, which causes an ulcer. 
 
Take Esohap-IT Capsule 30-60 minutes before food/meal. Swallow Esohap-IT Capsule as a whole with a glass of water; do not chew or crush it. You are advised to take Esohap-IT Capsule for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as headache, flatulence, stomach pain, constipation, and diarrhoea. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.
 
On long-term treatment, Esohap-IT Capsule may cause osteoporosis, hypomagnesemia (low levels of magnesium), and may reduce the absorption of vitamin B12. Consult your doctor if you are pregnant or breastfeeding. Esohap-IT Capsule may cause dizziness, so drive only if you are alert. Esohap-IT Capsule should not be given to children as safety has not been established. Avoid consuming alcohol along with Esohap-IT Capsule as it could lead to increased drowsiness and can elevate the production of stomach acid. Keep your doctor informed about all the medicines and your health condition to rule out any side-effects.

Esohap-IT Capsule is a combination medicine used to treat acidity, gastro-oesophageal reflux disease (GERD), stomach ulcer and heartburn. Esohap-IT Capsule is a combination of two drugs, namely: Esomeprazole and Itopride. Esomeprazole belongs to a group of medicines called proton pump inhibitors, whereas itopride belongs to a group of medicines called prokinetic agents. Esomeprazole works by blocking the action of an enzyme called the gastric proton pump, responsible for the production of stomach acid. Itopride works by accelerating the gastric emptying time, thereby increasing the movement of the food pipe, intestine and stomach. Besides this, Itopride also has anti-emetic action, which prevents the symptom of nausea and vomiting. Together, Esohap-IT Capsule helps in preventing acid reflux, thereby providing relief from hyperacidity, ulcers and heartburn.  

Do not take Esohap-IT Capsule if you are allergic to any of its contents; if you are taking nelfinavir (anti-HIV); if you have a gastrointestinal haemorrhage, mechanical obstruction or perforation, epilepsy, mania, porphyria, or cardiac impairment. Inform your doctor before taking Esohap-IT Capsule if you have severe liver or kidney problems; if you are due to have Chromogranin A test. Consult your doctor if you experience unexplained weight loss, stomach pain, indigestion, vomit food or blood, or if you pass black stools. On long-term treatment, Esohap-IT Capsule may cause osteoporosis, hypomagnesemia (low levels of magnesium), and may reduce the absorption of vitamin B12. Consult your doctor if you are pregnant or breastfeeding. Esohap-IT Capsule may cause dizziness, so drive only if you are alert. Esohap-IT Capsule should not be given to children as safety has not been established. Avoid consuming alcohol along with Esohap-IT Capsule as it could lead to increased drowsiness and can elevate the production of stomach acid. 

• Inform your doctor if you are due to have Chromogranin A test.
• Regular tests of magnesium and calcium are suggested if you are on long-term treatment with Esohap-IT Capsule .